Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

5.4%

6 terminated/withdrawn out of 111 trials

Success Rate

86.4%

-0.1% vs industry average

Late-Stage Pipeline

22%

24 trials in Phase 3/4

Results Transparency

8%

3 of 38 completed trials have results

Key Signals

21 recruiting3 with results

Enrollment Performance

Analytics

N/A
35(46.1%)
Phase 3
23(30.3%)
Phase 2
14(18.4%)
Phase 1
3(3.9%)
Phase 4
1(1.3%)
76Total
N/A(35)
Phase 3(23)
Phase 2(14)
Phase 1(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (111)

Showing 20 of 111 trials
NCT07435623Recruiting

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Role: lead

NCT03256916Phase 3Completed

Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

Role: lead

NCT03005743Not ApplicableCompleted

Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial

Role: lead

NCT06644846Not ApplicableRecruiting

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

Role: lead

NCT05102240Recruiting

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Role: lead

NCT07400809Recruiting

Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.

Role: lead

NCT03997110Not ApplicableRecruiting

Palliative Radiation for Advanced Cervical Cancer

Role: lead

NCT07404176Phase 2Recruiting

Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

Role: lead

NCT07196033Recruiting

Asian Gynecological Brachytherapy Registry in Cervical Cancer

Role: lead

NCT01279135Phase 3Completed

Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix

Role: lead

NCT06804135Recruiting

Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

Role: lead

NCT07179757Recruiting

Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.

Role: lead

NCT07164534Phase 3Not Yet Recruiting

A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Role: lead

NCT07290972Recruiting

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

Role: lead

NCT07354087Active Not Recruiting

Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry

Role: lead

NCT03853655Not ApplicableCompleted

Adjuvant Radiotherapy in Early Stage Oral Cancers

Role: lead

NCT07342231Recruiting

FAPi PET in Pancreatic Ductal Adenocarcinoma

Role: lead

NCT03974893Active Not Recruiting

Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia

Role: collaborator

NCT05592938Not ApplicableRecruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Role: collaborator

NCT07185672Phase 3Recruiting

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

Role: lead